(HealthDay)—Cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are effective for reducing symptoms of anxiety in childhood, according to a review published online Aug. 31 in JAMA Pediatrics.
When treating anxiety, clinicians have options between multiple treatments. Specifically, cognitive behavioral therapy (CBT) and pharmacotherapy exist for childhood anxiety disorders. Researchers conducted a literature search to compare the effectiveness of the two treatments....
They are most often used for depression but are also widely prescribed to help manage symptoms of anxiety and anxiety-related disorders, including generalized anxiety, social anxiety, obsessive-compulsive disorder and post-traumatic stress disorder (PTSD). The prototype drug in this group is fluoxetine...
aAlthough SSRIs are considered to be a first-line treatment for the most of anxiety disorders benzodiazepines are still widely used in clinical practice despite the risk of dependence and strong recommendation for their use as a second-line. Combination of the SSRIs and the benzodiazepines is wid...
OBJECTIVE: To compare the effectiveness of serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) for anxiety and mood disorders in a naturalistic setting. METHODS: 114 of 2,000 outpatients drawn from a private facility with a diagnosis of mood or anxiety disorder had two separa...
antidepressantsSynonymsSerotonin antidepressantsDefinition Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs primarily developed for the treatment of major depressive disorder (MDD), although most agents now have additional indications, particularly for the treatment of various anxiety ...
Both are effective at treating the symptoms of depression (and, for some drugs, anxiety disorders as well). But what are the differences between NDRIs vs SSRIs? Let’s go into more detail on how SSRIs and NDRIs work to treat depression and anxiety, as well as the major differences betwee...
Overall, the response rate to treatment for patients who completed a trial was 63.2% for SSRIs and 68.2% for TCAs ( P = 0.038). For the intention... DC Steffens,KRR Krishnan,MJ Helms - 《Depression & Anxiety》 被引量: 500发表: 1997年 Paroxetine. An update of its pharmacology and th...
11. Steffens DC, Krishnan KR, Helms MJ. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. Depress Anxiety. 1997;6(1):10-18. 12. Kim T, Xu C, Amsterdam JD. Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatme...
Although no one can deny the therapeutic validity of antidepressants, especially SSRIs, some considerations must be made, especially concerning their effectiveness in long-term therapy. The consumption of antidepressants (mainly SSRIs) at clinically relevant concentrations would play a role in tissue mut...